Cargando…

IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report

BACKGROUND: The flare of immune-mediated disease following coronavirus disease of 2019 (COVID-19) vaccination is a rare adverse event following immunization. De novo, as well as relapsing IgA nephropathy (IgAN) cases, have been reported following either mRNA-1273 (Moderna) or BNT162b2 (Pfizer-BioNTe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Shota, Zheng, Shuling, Rashidi, Arash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988530/ https://www.ncbi.nlm.nih.gov/pubmed/35392838 http://dx.doi.org/10.1186/s12882-022-02769-9

Ejemplares similares

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors
por: Moriyama, Takahito, et al.
Publicado: (2020)

Comparative analysis between the safety and efficacy of oral corticosteroids versus corticosteroids pulse therapies in IgA nephropathy
por: Wang, Yu, et al.
Publicado: (2023)

Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
por: Pozzi, Claudio, et al.
Publicado: (2012)

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy
por: Sato, Hirotaka, et al.
Publicado: (2021)

Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

IgA nephropathy following COVID-19 vaccination: challenges and perspectives
por: Niel, Olivier, et al.
Publicado: (2022)

New-onset IgA nephropathy following COVID-19 vaccination
por: Ma, Yaohui, et al.
Publicado: (2022)

The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
por: Liang, Mengjun, et al.
Publicado: (2022)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

IgA Nephropathy in a Patient Treated with Adalimumab
por: Mertelj, Tonja, et al.
Publicado: (2021)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study
por: Si, Feng-Lei, et al.
Publicado: (2023)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Correction to: New-onset IgA nephropathy following COVID-19 vaccination
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020)

Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy
por: Zhang, Yu, et al.
Publicado: (2023)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Diagnostik und Therapie IgA Nephropathie – 2023
por: Schimpf, Judith, et al.
Publicado: (2023)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination
por: Nihei, Yoshihito, et al.
Publicado: (2022)

Elasomeran: IgA nephropathy: case report
Publicado: (2022)

Tozinameran: IgA nephropathy: case report
Publicado: (2022)

Elasomeran: IgA nephropathy: case report
Publicado: (2022)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9mu2mn8rdbsqhptapgv9sfu8da